
Thermo Fisher Scientific PSMC3 Monoclonal Antibody (OTI1C10), TrueMAB
PSMC3 단백질을 인식하는 Mouse IgG2a 형 단클론 항체로 Western blot, IHC, ICC/IF에 사용 가능. 인간, 개, 랫트 반응성. 동결건조 형태이며 PBS buffer에 trehalose 포함. 연구용으로만 사용.
- 카탈로그번호
- CF500928
- 판매단위
- pk
카탈로그
1개 옵션 · 카탈로그 번호를 클릭하면 복사됩니다Thermo Fisher Scientific · Thermo Fisher Scientific PSMC3 Monoclonal Antibody (OTI1C10), TrueMAB
Thermo Fisher Scientific PSMC3 Monoclonal Antibody (OTI1C10), TrueMAB
Applications and Tested Dilutions
| Application | Tested Dilution |
|---|---|
| Western Blot (WB) | 1:2,000 |
| Immunohistochemistry (Paraffin) (IHC (P)) | 1:50 |
| Immunocytochemistry (ICC/IF) | 1:100 |
Product Specifications
| Specification | Description |
|---|---|
| Species Reactivity | Dog, Human, Rat |
| Host / Isotype | Mouse / IgG2a |
| Class | Monoclonal |
| Type | Antibody |
| Clone | OTI1C10 |
| Immunogen | Full length human recombinant protein of human PSMC3 produced in HEK293T cell |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Concentration | 1 mg/mL |
| Purification | Affinity chromatography |
| Storage Buffer | PBS, pH 7.3, with 8% trehalose |
| Contains | No preservative |
| Storage Conditions | -20°C, Avoid Freeze/Thaw Cycles |
| Shipping Conditions | Ambient (domestic); Wet ice (international) |
Product Specific Information
For reconstitution, add 100 µL distilled water to achieve a final antibody concentration of approximately 1 mg/mL.
For conjugation experiments using this carrier-free antibody, perform an additional round of desalting (recommended: Zeba Spin Desalting Columns, 7K MWCO, 0.5 mL, Product #89882).
Target Information
This gene encodes a WASP interacting protein (WIP)-related protein. It plays a role in WASP-mediated organization of the actin cytoskeleton and may link the activated platelet-derived growth factor receptor to the actin polymerization machinery.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Thermo Fisher Scientific 상품 둘러보기
전체보기문의
0개 · 배송·재고 문의는 실시간 상담이 빠릅니다아직 등록된 문의가 없어요.
